GSK President Acquires 9.414 Notional Depositary Shares

The transaction entry ties the notional ADS acquisition to the President’s supplemental savings plan account.

Rhea-AI Filing Summary

GSK plc reported that its President, Maya Martinez-Davis, acquired 9.414 notional American Depositary Shares (ADS) within her GSK Executive Supplemental Savings Plan account. The transaction was listed at a price of $50.7200 on September 22, 2026, with the New York Stock Exchange shown as the place of transaction.

Key Figures

Notional ADS acquired: 9.414 notional ADS Transaction price: $50.7200

2 metrics

Notional ADS acquired 9.414 notional ADS Transaction dated September 22, 2026

Transaction price $50.7200 Transaction dated September 22, 2026

Key Terms

American Depositary Shares, notional ADS, Executive Supplemental Savings Plan, PDMR

4 terms

American Depositary Shares financial

"Description of the financial instrument: American Depositary Shares (‘ADS’)"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

notional ADS financial

"Acquisition of notional ADS within Ms Martinez-Davis’s GSK Executive Supplemental Savings Plan account"

Executive Supplemental Savings Plan financial

"within Ms Martinez-Davis’s GSK Executive Supplemental Savings Plan account"

PDMR regulatory

"Details of PDMR/person closely associated with them (‘PCA’)"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many notional ADS did GSK President Maya Martinez-Davis acquire, and at what price?

Maya Martinez-Davis acquired 9.414 notional ADS at a listed price of $50.7200 on September 22, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 10:44 AM Accepted by SEC EDGAR 09/24/2026 - 10:44 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the ‘Company’)

Transaction notification

1.	Details of PDMR/person closely associated with them (‘PCA’)
a)	Name	Maya Martinez-Davis
b)	Position/status	President, US
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares (‘ADS’) ISIN: US37733W2044
b)	Nature of the transaction	Acquisition of notional ADS within Ms Martinez-Davis’s GSK Executive Supplemental Savings Plan account
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$50.7200	9.414
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2026-09-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: September 24, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc